Glaxo Receives France's First Predatory Pricing Fine
France's competition regulator has penalized GlaxoSmithKline PLC $13.2 million, the country's first fine for predatory pricing, for allegedly pricing an injectable antibiotic below costs to prevent generics makers from entering the...To view the full article, register now.
Already a subscriber? Click here to view full article